InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Ultragenyx Pharmaceutical Inc.. Officer active across 1 company, notably Arcturus Therapeutics Holdings Inc.. Cumulatively, 2 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €68.6m. History available since 10 August 2021. The latest transaction was disclosed on 10 August 2021 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
725,000 shares@ US$55.4419.69% mcap50.0% of flowCommon StockSEC:0001209191-21-051182:0
725,000 shares@ US$55.4450.0% of flowCommon StockSEC:0001209191-21-051182
2 of 2 declarations
